38

COVID-19 pandemiyasi butun dunyo bo‘ylab sog‘liqni saqlash tizimlariga, ayniqsa, akusherlik va ginekologiya sohalariga jiddiy ta’sir ko‘rsatdi. SARS-CoV-2 bilan infeksiyalangan homilador ayollar gestatsiya davriga qarab o‘zgaruvchi asoratlar xavfiga duch keladi. Ushbu tadqiqotning maqsadi COVID-19ning homiladorlikning turli gestatsion davrlariga ta’sirini tahlil qilish va har bir trimestga mos profilaktika choralarini taklif etishdan iborat. 2020–2023-yillarda COVID-19 bilan infeksiyalangan homilador ayollarning tibbiy ma’lumotlari retrospektiv tahlil qilindi. Natijalar homiladorlikning har bir trimestrida turli asoratlar xavfini aniqlab, trimestga xos profilaktika choralarini ishlab chiqish zarurligini tasdiqlaydi. Birinchi trimestrda homiladorlikni to‘xtatish va yallig‘lanish jarayonlari asosiy xavflar hisoblanadi, ikkinchi trimestrda preeklampsiya va gestatsion gipertenziya xavfi yuqori. Uchinchi trimestrda esa og‘ir respirator asoratlar va muddatidan oldin tug‘ruq xavfi yuqori bo‘ladi. Ushbu tadqiqot natijalari COVID-19 bilan bog‘liq asoratlarning oldini olish va davolash uchun maxsus tibbiy protokollarni takomillashtirish uchun muhim manba hisoblanadi

  • Read count 38
  • Date of publication 31-12-2024
  • Main LanguageO'zbek
  • Pages7-14
Ўзбек

COVID-19 pandemiyasi butun dunyo bo‘ylab sog‘liqni saqlash tizimlariga, ayniqsa, akusherlik va ginekologiya sohalariga jiddiy ta’sir ko‘rsatdi. SARS-CoV-2 bilan infeksiyalangan homilador ayollar gestatsiya davriga qarab o‘zgaruvchi asoratlar xavfiga duch keladi. Ushbu tadqiqotning maqsadi COVID-19ning homiladorlikning turli gestatsion davrlariga ta’sirini tahlil qilish va har bir trimestga mos profilaktika choralarini taklif etishdan iborat. 2020–2023-yillarda COVID-19 bilan infeksiyalangan homilador ayollarning tibbiy ma’lumotlari retrospektiv tahlil qilindi. Natijalar homiladorlikning har bir trimestrida turli asoratlar xavfini aniqlab, trimestga xos profilaktika choralarini ishlab chiqish zarurligini tasdiqlaydi. Birinchi trimestrda homiladorlikni to‘xtatish va yallig‘lanish jarayonlari asosiy xavflar hisoblanadi, ikkinchi trimestrda preeklampsiya va gestatsion gipertenziya xavfi yuqori. Uchinchi trimestrda esa og‘ir respirator asoratlar va muddatidan oldin tug‘ruq xavfi yuqori bo‘ladi. Ushbu tadqiqot natijalari COVID-19 bilan bog‘liq asoratlarning oldini olish va davolash uchun maxsus tibbiy protokollarni takomillashtirish uchun muhim manba hisoblanadi

№ Name of reference
1 1.Chen, H., Guo, J., Wang, C., Luo, F., Yu, X., Zhang, W., et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet, 2020;395(10226):809–815. DOI: 10.1016/S0140-6736(20)30360-3.2.Di Mascio, D., Khalil, A., Saccone, G., Rizzo, G., Buca, D., Liberati, M., et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. American Journal of Obstetrics & Gynecology MFM, 2020;2(2):100107. DOI: 10.1016/j.ajogmf.2020.100107.3.Khalil, A., Hill, R., Ladhani, S., Pattisson, K., & O’Brien, P. SARS-CoV-2 in pregnancy: symptomatic pregnant women are only the tip of the iceberg. American Journal of Obstetrics & Gynecology, 2020;223(2):296–297. DOI: 10.1016/j.ajog.2020.05.005.4.Knight, M., Bunch, K., Vousden, N., Morris, E., Simpson, N., Gale, C., et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in the UK: a national population-based cohort study. BMJ, 2020;369. DOI: 10.1136/bmj.m2107.5.Shukurov, F., & Mamajanova , D. (2022). cytokine status in pregnant women vaccinated against Covid-19.journal of education and scientific medicine,2(3), 90-94. Retrieved from https://journals.tma.uz/index.php/jesm/article/view/356M.M.Salohiddinova, M.J.Xusanova. Covid-19 davrida homiladorlik kechishi va davolash. 2021;2:45-50. Amaliy va tibbiyot fanlari ilmiy jurnali, VOL. 2 NO. 8 (2023) 6.Rolnik, D. L., Wright, D., Poon, L. C., O'Gorman, N., Syngelaki, A., de Paco Matallana, C., et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. The New England Journal of Medicine, 2017;377(7):613–622. DOI: 10.1056/NEJMoa1704559.7.Холова З.Б.Шукуров Ф.И.Морфологические особенности фетоплацентарной дисфункции у беременных с COVID-19//Материалы конгресса «XVIIмеждународный конгресс по репродуктивной медицине»М., 2023 –С.133-134.8.Wastnedge, E. A. N., Reynolds, R. M., van Boeckel, S. R., Stock, S. J., Denison, F. C., Maybin, J. A., & Critchley, H. O. D. Pregnancy and COVID-19. Physiological Reviews, 2021;101(1):303–318. DOI: 10.1152/physrev.00024.2020.9.Wastnedge, E. A. N., Stock, S. J., Garcia-Flores, V., Gee, J., Mir, Z., & Acharya, G. COVID-19 and pregnancy: The impact of the pandemic on maternal and perinatal outcomes. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2021;256:172–178. DOI: 10.1016/j.ejogrb.2020.11.055.10.Wu, Y., Liu, C., Dong, L., Zhang, C., Chen, Y., Liu, J., et al. COVID-19 in pregnant women: data on the safety of vaginal delivery and breastfeeding. BJOG: An International Journal of Obstetrics & Gynecology, 2020;127(9):1109–1115. DOI: 10.1111/1471-0528.16276.11.Kholova Z.B.,Shukurov F. Retrospective analysis of fetoplacental dysfunction in pregnant women with coronavirus infection // Journal of Educational Scientific Medicine,No2, 2023.-С.82-87.12.Yang, H., Sun, G., Tang, F., Peng, M., Gao, Y., Peng, J., et al. Clinical characteristics and outcomes of pregnant women suspected of coronavirus disease 2019. Journal of Infection, 2020;81(1). DOI: 10.1016/j.jinf.2020.04.003.
Waiting